financetom
Business
financetom
/
Business
/
Trump tariffs may push Airbus to prioritise non-US clients, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump tariffs may push Airbus to prioritise non-US clients, CEO says
Feb 20, 2025 9:29 AM

(Reuters) - Airbus could prioritise deliveries to non-U.S. customers if tariffs imposed by U.S. President Donald Trump were to disrupt the company's imports in the country, CEO Guillaume Faury said in an interview with CNBC on Thursday.

Trump said on Wednesday he will announce new tariffs over the next month or sooner, adding to duties he has introduced since taking office, which could affect the aerospace industry and its suppliers among other sectors.

"We have a large demand from the rest of the world, so [if] we face very significant difficulties to deliver to the U.S., we can also adapt by bringing forward deliveries to other customers which are very eager to get planes", Faury said.

Earlier in the day, he had told journalists while presenting Airbus' annual results in Toulouse that the group "should not be directly impacted by tariffs".

"Indeed, we are buying a lot from the U.S. We are selling to the U.S., we manufacture, we assemble, we develop in the U.S. like few other companies ... and we believe tariffs in this industry would be lose-lose," he said at the press conference.

Airbus spends 15 billion euros ($15.70 billion) annually with its network of more than 2,000 suppliers in the U.S., which is the largest single supplier to the company, according to the company's website.

The France-based planemaker, the main rival of Boeing ( BA ), has expanded U.S. operations in recent years, with its Alabama plant employing more than 2,000 people in the final assembly of the A320 and A220 aircraft family.

But the group is having to deal with supply chain bottlenecks that are straining an aerospace industry already challenged by a shortage of experienced workers.

Airbus excluded the potential impact from threatened trade tariffs from the 2025 financial guidance it disclosed on Thursday, saying it will adapt accordingly.

"We have not taken major actions so far... we are more in a wait-and-see mode," Faury told analysts during the company's earnings call.

($1 = 0.9555 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the...
Automotive Properties REIT Declares January 2025 Distribution
Automotive Properties REIT Declares January 2025 Distribution
Jan 15, 2025
03:49 PM EST, 01/15/2025 (MT Newswires) -- Automotive Properties REIT (APR-UN.TO) Wednesday declared a distribution of $0.067 per REIT unit for the month of January, representing $0.804 per REIT unit on an annualized basis. This is consistent with December's cash distribution. Payment will be made on Feb. 18 to unitholders of record on Jan. 31. Price: 10.66, Change: +0.08, Percent...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
Jan 15 (Reuters) - Gilead Sciences ( GILD ) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said...
Senators demand US trade chief Tai halt late talks on investor protections
Senators demand US trade chief Tai halt late talks on investor protections
Jan 15, 2025
WASHINGTON (Reuters) - A bipartisan group of U.S. senators on Wednesday called on U.S. Trade Representative Katherine Tai to stop secret negotiations with Mexico, Canada and Colombia that would weaken investor protections in some U.S. free trade deals during the Biden administration's final days. The letter, led by Senate Finance Committee Chairman Mike Crapo, a Republican, and the panel's top...
Copyright 2023-2025 - www.financetom.com All Rights Reserved